Free WCG Foundation webinars offer insights on speeding access to experimental drugs for intermediate-size patient populations

Free WCG Foundation webinars offer insights on speeding access to experimental drugs for intermediate-size patient populations

Presenters include Richard Klein, formerly of FDA, and Marjorie Speers of WCGF

ATLANTA, Ga., Jan. 9, 2018—WCG Foundation will host free webinars Jan. 25 and Feb. 5 on how to streamline the application process for experimental medications for intermediate-size populations of desperately ill patients.

The webinars—“Intermediate-Size Patient Populations INDs: What Are They, When Should They Be Used, and Who May Apply for Them?”—feature Richard Klein, former director of the Food and Drug Administration Patient Liaison Program Office, and Marjorie A. Speers, Ph.D., executive director, WCGF.

Read More >>

 

 

Comments

comments

2018-07-02T14:49:35+00:00January 9, 2018|News|